Early research (Phase 1)Not Yet RecruitingNCT07432100
What this trial is testing
Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia
Who this might be right for
Acute Myeloid LeukemiaChimeric Antigen Receptor T-cellUniversal CLL1 CAR-T
Mingfeng Zhao 20